PFO Closure Without Prior Stroke is NOT Justified
PFO closure is not indicated in patients without a history of stroke, TIA, or documented paradoxical embolism. All current evidence and guidelines specifically address PFO closure only in the context of secondary prevention after cryptogenic stroke or TIA—there is no established role for primary prevention in asymptomatic individuals with incidentally discovered PFO 1, 2.
Why PFO Closure Requires a Prior Embolic Event
The fundamental principle underlying PFO closure is secondary stroke prevention, not primary prevention. The evidence base is entirely built on patients who have already experienced a cryptogenic stroke or TIA:
- PFO is extremely common: Present in approximately 25% of all adults in the general population 3
- Most PFOs never cause problems: The vast majority of people with PFO will never experience a stroke
- Causality cannot be established without an event: It is impossible to determine whether a PFO will cause a future stroke in someone who has never had one 1
The Evidence Base Explicitly Excludes Primary Prevention
All major guidelines and randomized controlled trials focus exclusively on patients with prior cryptogenic stroke:
- The 2018 BMJ guideline states that available data specifically address patients with "cryptogenic ischaemic stroke or transient ischaemic attack and a PFO" 1
- The 2024 European Stroke Organisation guidelines recommend PFO closure "in selected patients aged 18-60 years in whom no other evident cause of stroke is found but a PFO (i.e. PFO-associated stroke)" 2
- All six major randomized trials pooled in meta-analyses enrolled only patients with prior cryptogenic stroke, showing an annualized stroke reduction from 1.09% to 0.47% over median 57-month follow-up 3
Risk-Benefit Analysis Favors Observation in Asymptomatic Patients
Without a prior embolic event, the risk-benefit calculation does not support closure:
Risks of closure include:
- Atrial fibrillation (3-4 fold increased risk) 3, 4
- Major procedural complications (1.5-2.3%) 5
- Device-related adverse events
- Exposure to antiplatelet therapy post-procedure
Benefits are unproven because:
- The baseline annual stroke risk in asymptomatic PFO patients approximates the general population risk
- No trials have evaluated primary prevention
- The number needed to treat would be prohibitively high
The Only Potential Exception: PFO with DVT
The American Academy of Neurology notes that "in the setting of PFO and deep vein thrombosis, PFO closure by a transcatheter device might be considered depending on the risk of recurrent deep vein thrombosis" 1. This represents documented paradoxical embolism risk, not truly asymptomatic PFO.
Clinical Algorithm for PFO Management
If PFO discovered incidentally (no stroke/TIA):
- Do not close - No indication exists
- Counsel patient that PFO is common (1 in 4 adults)
- Address standard vascular risk factors
- No specific follow-up imaging needed
- Consider DVT prophylaxis in high-risk situations (prolonged immobility, surgery)
If patient has had cryptogenic stroke/TIA:
- Complete thorough stroke workup to exclude other causes
- Calculate RoPE score and apply PASCAL classification 3, 2
- Consider closure if age 18-60 years with high-risk features (large shunt, atrial septal aneurysm)
- Refer to interventional cardiology for shared decision-making
Common Pitfall to Avoid
Do not be swayed by patient anxiety about an incidentally discovered PFO. The American Academy of Neurology specifically emphasizes that "clinicians must counsel patients considering percutaneous PFO closure that having a PFO is common in the general population; it is impossible to determine with certainty whether their PFO caused their stroke" 1. This counseling applies even more strongly to patients who have never had an event—there is no way to predict if their PFO will ever cause problems, and the procedure carries definite risks.